Chen Dongfeng

Chen Dongfeng, Senior Embryologist | Director of the Reproductive Laboratory Center, Boten Huishi Fertility Hospital

Basic Employment Identity

Chen DongfengForBoten Huishi Reproductive Hospital(Huishi DOC Hospital)Senior Embryologist, serving as the Director of the Reproductive Laboratory Center at the hospital. As a core technical backbone of the hospital’s embryo laboratory, he/she has been deeply engaged in assisted reproductive technology for many years, specializing in embryo culture and micromanipulation techniques, and is primarily responsible for overseeing all technical operations and quality control throughout the embryo laboratory workflow.

Professional Education Background

Chen Dongfeng graduated from the State Key Laboratory of Reproductive Regulation and Transgenic Research at Guangxi Medical University, possessing a solid academic foundation in reproductive embryology that provides robust theoretical support for laboratory technical operations.

Hands-on laboratory experience

Chen Dongfeng has over 10 years of experience in assisted reproductive technology (ART) embryology laboratories. He independently completes more than 3,000 IVF/ICSI laboratory cycles per year and has accumulated extensive experience in handling complex cases. He is capable of independently performing the full range of laboratory procedures associated with second-generation IVF (intracytoplasmic sperm injection, ICSI) and third-generation IVF (preimplantation genetic testing, PGT). The precision and stability of his techniques are critical factors ensuring high-quality embryo development.

Core Technical Expertise

Chen Dongfeng’s technical expertise covers all core aspects of the assisted reproductive technology (ART) embryo laboratory, specifically including:

1. Oocyte and Embryo Quality AssessmentIt enables precise grading and assessment of oocyte maturity and embryonic development status, providing core laboratory-level reference data for formulating clinical embryo transfer protocols.

2. Intracytoplasmic Sperm Injection (ICSI)For male factor infertility involving severe oligospermia, asthenospermia, and abnormal sperm morphology, as well as cases with prior conventional IVF fertilization failure or requiring the use of cryopreserved sperm, high-precision intracytoplasmic sperm injection (ICSI) helps improve fertilization efficiency.

3. Embryo transfer procedureCollaborate with clinicians to perform precise intrauterine embryo transfer of high-quality embryos under ultrasound guidance.

4. Assisted Hatching and Embryo BiopsyPerform assisted hatching on embryos with zona pellucida abnormalities; provide standardized embryo biopsy sampling for preimplantation genetic testing (PGT) to ensure the quality of samples and the accuracy of subsequent genetic test results.

5. Cryopreservation of Gametes and EmbryosWe employ vitrification cryopreservation technology for the freezing and thawing of embryos and oocytes, ensuring high post-thaw survival rates. We also conduct semen quality assessment and sperm cryopreservation to provide technical support for fertility preservation needs.

   

Adapted Service Scenarios

Chen Dongfeng's technical expertise covers laboratory support scenarios for a wide range of infertility treatments, and is particularly suitable for providing relevant technical services to the following groups:

• Patients with male factor infertility due to severe oligoasthenozoospermia who require ICSI treatment;

• Couples requiring preimplantation genetic screening/diagnosis (PGS/PGD) and high-quality embryo biopsy procedures;

• Individuals seeking fertility preservation who require cryopreservation of oocytes, embryos, or sperm;

• Embryology laboratory technical support for complex and challenging cases, including advanced maternal age conception planning, recurrent implantation failure, and recurrent miscarriage.

  

Background of the Affiliated Medical Platform

The Moding Huishi Reproductive Hospital, where Chen Dongfeng works, is a high-end specialized hospital for assisted reproductive genetics approved by the Lao Ministry of Public Health, located in the financial center of the Boten Special Economic Zone in Laos. The first phase of the hospital’s construction covers an area of nearly 4,000 square meters, including laminar flow embryo laboratories and reproductive genetics laboratories totaling approximately 1,100 square meters, with a quality management system established in accordance with U.S. standards. The hospital is equipped with internationally advanced reproductive genetic devices, such as Illumina sequencers, Japanese NARISHIGE micromanipulation systems, British RI laser hatching systems, Roche immunoassay analyzers, and IVFtech workstations. It has built a molecular diagnostic platform based on next-generation sequencing (NGS) technology, offering supporting services including high-resolution karyotyping analysis, single-gene disease screening, and genetic counseling. The hospital operates a service center in Kunming, China, providing one-stop services to patients, including consultation coordination, travel arrangements, and full-process Chinese-speaking escort support.

Academic Achievements

Beyond his laboratory technical work, Chen Dongfeng has continued to conduct research on assisted reproductive technology embryology and has published dozens of academic papers in core journals both domestically and internationally.